Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M44,502Revenue $M20,314Net Margin (%)12.6Z-Score2.3
Enterprise Value $M54,862EPS $1.5Operating Margin %15.9F-Score8
P/E(ttm))17.3Cash Flow Per Share $5.9Pre-tax Margin (%)14.4Higher ROA y-yY
Price/Book1.910-y EBITDA Growth Rate %14.4Quick Ratio0.7Cash flow > EarningsY
Price/Sales2.25-y EBITDA Growth Rate %-1.3Current Ratio1.1Lower Leverage y-yY
Price/Cash Flow7.3y-y EBITDA Growth Rate %89.0ROA % (ttm)5.5Higher Current Ratio y-yY
Dividend Yield %2.2Insider Buy (3m)0ROE % (ttm)11.0Less Shares Outstanding y-yN
Payout Ratio %38.0Shares Outstanding M851ROI % (ttm)0.2Gross Margin Increase y-yY

Gurus Latest Trades with TEVA

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
TEVAMichael Price 2014-06-30 Add0.71%$48.69 - $54.06
($51.09)
$ 52.212%Add 28.73%500,000
TEVAGeorge Soros 2014-06-30 Reduce-1.59%$48.69 - $54.06
($51.09)
$ 52.212%Reduce -29.45%7,273,240
TEVAVanguard Health Care Fund 2014-06-30 Reduce-0.73%$48.69 - $54.06
($51.09)
$ 52.212%Reduce -40.54%7,344,400
TEVAJames Barrow 2014-06-30 Reduce-0.19%$48.69 - $54.06
($51.09)
$ 52.212%Reduce -18.5%10,868,770
TEVAGeorge Soros 2014-03-31 Add0.52%$39.88 - $50.22
($45.91)
$ 52.2114%Add 10.67%10,310,041
TEVADavid Dreman 2014-03-31 Add0.15%$39.88 - $50.22
($45.91)
$ 52.2114%Add 24.43%183,323
TEVAJohn Keeley 2014-03-31 Buy 0.04%$39.88 - $50.22
($45.91)
$ 52.2114%New holding, 47435 sh.47,435
TEVAGeorge Soros 2013-12-31 Add1.96%$36.59 - $41.7
($39.39)
$ 52.2132%Add 158.2%9,316,000
TEVAJames Barrow 2013-12-31 Add0.31%$36.59 - $41.7
($39.39)
$ 52.2132%Add 79.64%12,143,563
TEVAMichael Price 2013-12-31 Add0.26%$36.59 - $41.7
($39.39)
$ 52.2132%Add 14.29%400,000
TEVAGeorge Soros 2013-09-30 Buy 1.5%$37.43 - $41.27
($39.03)
$ 52.2134%New holding, 3608000 sh.3,608,000
TEVAVanguard Health Care Fund 2013-09-30 Add0.23%$37.43 - $41.27
($39.03)
$ 52.2134%Add 15.71%13,145,600
TEVADavid Abrams 2013-09-30 Sold Out -5.8%$37.43 - $41.27
($39.03)
$ 52.2134%Sold Out0
TEVARonald Muhlenkamp 2013-06-30 Reduce-0.99%$37.8 - $40.23
($38.94)
$ 52.2134%Reduce -41.05%169,660
TEVAGeorge Soros 2013-06-30 Sold Out -0.02%$37.8 - $40.23
($38.94)
$ 52.2134%Sold Out0
TEVAVanguard Health Care Fund 2013-03-31 Add0.21%$37.19 - $41.06
($38.57)
$ 52.2135%Add 13.37%11,361,300
TEVAJames Barrow 2013-03-31 Add0.2%$37.19 - $41.06
($38.57)
$ 52.2135%Add 64.42%7,078,456
TEVAJohn Burbank 2013-03-31 Sold Out -0.11%$37.19 - $41.06
($38.57)
$ 52.2135%Sold Out0
TEVAGeorge Soros 2013-03-31 Reduce-0.04%$37.19 - $41.06
($38.57)
$ 52.2135%Reduce -66.67%50,000
TEVAMichael Price 2012-12-31 Add1.36%$36.95 - $42.52
($39.94)
$ 52.2131%Add 250%350,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

TEVA is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
TEVA Michael Price 2014-06-30500,0000.063.2+28.73%
TEVA Ronald Muhlenkamp 2014-06-30176,8550.021.6+0.81%
TEVA Jean-Marie Eveillard 2014-06-3020000
TEVA John Keeley 2014-06-3047,4350.010.05
TEVA Tom Gayner 2014-06-30694,0000.081
TEVA David Dreman 2014-06-30159,0900.020.63-13.22%
TEVA James Barrow 2014-06-3010,868,7701.280.77-18.5%
TEVA George Soros 2014-06-307,273,2400.852.9-29.45%
TEVA Vanguard Health Care Fund 2014-06-307,344,4000.861-40.54%
Premium Most recent portfolio changes are included for Premium Members only!


TEVA: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about TEVA :

    Quarterly/Annual Reports about TEVA:

      News about TEVA:

      Articles On GuruFocus.com
      The Gurus’ Favorite Asian Stocks Sep 06 2014 
      George Soros Reveals His Largest Stake Jul 23 2014 
      George Soros Keeps Buying TEVA, EQT, YPF, EGN, CZR And Keeps Selling GOOGL, BA, MSFT, HAR Jul 16 2014 
      Diamond Hill Capital Comments on Teva Pharmaceutical Industries Ltd Jun 26 2014 
      Diamond Hill Select Fund Commentary – First Quarter 2014 Jun 25 2014 
      Top Guru Held Asian Companies of the First Quarter Jun 03 2014 
      George Soros Reports Top Five Stocks May 23 2014 
      Richard Snow's Top Five Highlight Finance and Healthcare Sectors May 14 2014 
      Wrong Marketing Lesson by Big Pharma May 03 2014 
      Should You Buy Actavis? Mar 18 2014 


      More From Other Websites
      [video] Check Point, Teva Are Smart Choices for 'Frugal' Investors Sep 17 2014
      OncoGenex Announces Completion of Patient Enrollment in the Phase 3 AFFINITY Trial of Custirsen in... Sep 16 2014
      Teva Canada Announces the Launch of (Pr)Teva-Ezetimibe, a Generic of (Pr)Ezetrol® Sep 15 2014
      Teva Presents Gene Expression Analysis at Joint Actrims-Ectrims Meeting Demonstrating Copaxone®... Sep 12 2014
      Teva Presents New Clinical Safety Data in RRMS Patients Treated with Laquinimod for Two or More... Sep 12 2014
      Teva Presents New Clinical Safety Data in RRMS Patients Treated with Laquinimod for Two or More... Sep 12 2014
      Teva Presents New Data Which Demonstrate Reduction of Injection-Related Adverse Events with the Less... Sep 11 2014
      Teva Canada Announces the Launch of (Pr)Teva-Escitalopram, a Generic of (Pr)Cipralex® Sep 10 2014
      FTC sues AbbVie, Teva over generic AndroGel Sep 08 2014
      FTC sues AbbVie, Teva over generic AndroGel Sep 08 2014
      Successful Completion of Phase III Program for Teva’s Reslizumab Two More Phase Iii Studies... Sep 08 2014
      Teva Wins Patent Litigation vs. AstraZeneca in UK Sep 04 2014
      Teva Announces Launch of Generic Baraclude® Tablets, 0.5mg and 1mg, in the United States Sep 04 2014
      Teva to Present at the Morgan Stanley Global Healthcare Conference Sep 04 2014
      Aereo, Teva-AstraZeneca, Cartoon Parody: Intellectual Property Sep 03 2014
      Data to be Presented at MS Boston 2014: Joint ACTRIMS-ECTRIMS Meeting Underscore Teva’s Commitment... Sep 03 2014
      Teva Launches SYNCareTM Home Administration Support Program for Patients on SYNRIBO® (Omacetaxine... Sep 03 2014
      UK court backs Teva rival to AstraZeneca lung drug Sep 03 2014
      UK court backs Teva rival to AstraZeneca lung drug Sep 03 2014
      UK court backs Teva rival to AstraZeneca lung drug Sep 03 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK